Ahmed Fozia Zahir, Cunnington Colin, Motwani Manish, Zaidi Amir Masood
Institute of Cardiovascular Sciences, University of Manchester, Manchester, United Kingdom; Manchester Heart Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, United Kingdom.
Institute of Cardiovascular Sciences, University of Manchester, Manchester, United Kingdom; Manchester Heart Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, United Kingdom.
Can J Cardiol. 2017 Aug;33(8):1066.e5-1066.e7. doi: 10.1016/j.cjca.2017.05.017. Epub 2017 May 30.
Subcutaneous implantable cardioverter defibrillators (S-ICDs) provide effective defibrillation, while also reducing the risk of long-term lead problems. However, S-ICDs do not offer bradycardia or antitachycardia pacing and therefore use has been limited. Combined implantation of an S-ICD with a leadless pacemaker (LP) has been proposed to overcome this limitation. Although a handful of combined S-ICD/LP implantations have been reported for Nanostim (St Jude Medical, St Paul, MN) as well as Micra LP (Medtronic, Minneapolis, MN) systems, none have documented delivery of appropriate shock therapies for spontaneous ventricular tachycardia. We report the first case of effective defibrillation for spontaneous ventricular tachycardia in a patient with combined Micra LP and S-ICD.
皮下植入式心律转复除颤器(S-ICD)可提供有效的除颤,同时还能降低长期导线问题的风险。然而,S-ICD不具备心动过缓或抗心动过速起搏功能,因此其应用受到限制。有人提出将S-ICD与无导线起搏器(LP)联合植入以克服这一限制。尽管已有少数关于Nanostim(圣犹达医疗公司,明尼苏达州圣保罗)以及Micra LP(美敦力公司,明尼阿波利斯,明尼苏达州)系统的S-ICD/LP联合植入的报道,但均未记录到针对自发性室性心动过速的适当电击治疗。我们报告了首例使用Micra LP和S-ICD联合植入的患者,其对自发性室性心动过速进行有效除颤的病例。